Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy

Blood and Lymphatic Cancer: Targets and Therapy

ISSN: 1179-9889


Editor-in-Chief: Dr Wilson Gonsalves

An international, peer reviewed, open access journal focusing on blood and lymphatic cancer research, identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient.

The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports, and extended reports.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

 

Latest articles:

- 5 records -

Polycythemia Vera: Barriers to and Strategies for Optimal Management

Duminuco A, Harrington P, Harrison C, Curto-Garcia N

Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:77-90

Published Date: 21 December 2023

Zanubrutinib in Mantle Cell Lymphoma Management: A Comprehensive Review

Alsuhebany N, Pan C, Holovac E, Do B, McBride A

Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:67-76

Published Date: 24 November 2023

Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article

Hussain M, Yellapragada S, Al Hadidi S

Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:33-57

Published Date: 15 September 2023


Read more articles